본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

한국임상약학회지 = Korean journal of clinical pharmacy v.21 no.3, 2011년, pp.270 - 275   피인용횟수: 2

Warfarin과 Simvastatin/Gemfibrozil의 약물 상호 작용 : 높은 수치의 ALT/AST, 횡문근 융해와 급성 신장 장애
Drug Interaction of Warfarin with Simvastatin / Gemfibrozil : high levels of ALT/AST, rhabdomyolysis and acute renal failure

윤현옥 ;    (미국 하워드 대학교 약학대학   );
  • 초록

    이 증례는 드물게 보는 경우로 simvastatin과 gemfibrozil을 오랫동안 함께 복용했음에도, 특이한 문제가 발현되지 않았지만, 이들을 warfarin와 함께 치료하는 경우, 아주 높은 alanine aminotransferase (ALT), aspartate aminotransferase(AST) 혈중 농도, rhabdomyolysis, 급성 신장 장애가 발생하였다. 그 후, Simvastatin와 gemfibrozil을 복용 중단시켰더니, ALT/AST는 빠르게 정상수치로 돌아온 경우이다. 이 증례 보고서는 의료인들에게 simvastatin과 gemfibrozil을 함께 혹은 따로 warfarin과 함께 복용시켜 치료할 경우, creatine phosphokinase (CPK) 와 creatinine 혈중 수치들을 포함하여 ALT/AST 농도들을 주의 깊게 모니터하도록 경각심을 주고자 한다.


  • 주제어

    ALT .   AST .   rhabdomyolysis .   acute renal failure .   simvastatin .   gemfibrozil .   warfarin.  

  • 참고문헌 (35)

    1. Mol MJ, Stuyt PM, Stalenhoef AF, van 't Laar A. Cholesterol synthesis inhibitors in hyperlipidaemia. Lancet 1988; 1: 597. 
    2. Schulzeck P, Bojanovski M, Jochim A, Canzler H, Bojanovski D. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Lancet 1988; 1: 611-3. 
    3. Bard JM, Luc G, Douste-Blazy P, et al., Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia. Eur J Clin Pharmacol 1989; 37: 545-50. 
    4. Boccuzzi SJ, Bocanegra TS, Walker JF, Shapiro DR, Keegan ME. Long-term safety and efficacy profile of simvastatin. Am J Cardiol 1991; 68: 1127-31. 
    5. Ayanian JZ, Fuchs CS, Stone RM. Lovastatin and rhabdomyolysis. Ann Intern Med 1988; 109 :682-3. 
    6. Corpier CL, Jones PH, Suki WN, et al., Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. Jama 1988; 260: 239-41. 
    7. Jacobson RH, Wang P, Glueck CJ. Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone. Jama 1997; 277: 296-7. 
    8. Lees RS, Lees AM. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole. N Engl J Med 1995; 333: 664-5. 
    9. Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli WE. Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet 1998; 351: 1929-30. 
    10. Becquemont L. [Drug interactions with antilipemics]. Therapie 2003; 58: 85-90. 
    11. Capone D, Stanziale P, Gentile A, Imperatore P, Pellegrino T, Basile V. Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients. Am J Nephrol 1999; 19: 411-5. 
    12. Ohno Y, Hisaka A, Suzuki H. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Clin Pharmacokinet 2007; 46: 681-96. 
    13. Fenneteau F, Poulin P, Nekka F. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. J Pharm Sci; 99: 486-514. 
    14. Yeo KR, Yeo WW. Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes. Br J Clin Pharmacol 2001; 51: 461-70. 
    15. Cvetkovic RS, Goa KL. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 2003;63: 769-802. 
    16. Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol; 32: 675-703. 
    17. Olsson AG, Rossner S, Walldius G, Carlson LA. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia. Proc R Soc Med 1976; 69 Suppl 2: 28-31. 
    18. Betteridge DJ, Higgins MJ, Galton DJ. Properties of sterol biosynthesis in human leukocytes: effects of gemfibrozil. Proc R Soc Med 1976; 69 Suppl 2: 104-6. 
    19. Knoll RW, Ciafone R, Galen M. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil. Conn Med 1993; 57: 593-4. 
    20. Armitage J, Bowman L, Wallendszus K, et al., Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet; 376: 1658-69. 
    21. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Saf 2004; 13: 417-26. 
    22. Backman JT, Kyrklund C, Kivisto KT, Wang JS, Neuvonen PJ. Plasma concentrations of active simvastatin acid are increased by gemfibrozil. Clin Pharmacol Ther 2000; 68: 122-9. 
    23. Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 2006; 80: 565-81. 
    24. Prueksaritanont T, Ma B, Yu N. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol 2003; 56: 120-4. 
    25. Franson JC. Enzyme activities in plasma, liver and kidney of black ducks and mallards. J Wildl Dis 1982;18: 481-5. 
    26. Dianzani MU. [Distribution of lactic acid oxidase in liver and kidney cells of normal rats and rats with fatty degeneration of the liver]. Arch Fisiol 1951 ;50 :181-6. 
    27. Barchetta I, Angelico F, Del Ben M, et al., Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med; 9: 85. 
    28. Figueroa RB, Klotz AP. The Effect of Whiskey and Low-Protein Diets on Hepatic Enzymes in Rats. Am J Dig Dis 1964; 9 :121-7. 
    29. Hofmann AF, Korman MG, Krugman S. Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B. Prospective study in five patients. Am J Dig Dis 1974; 19 :908-10. 
    30. Hickmott H, Wynne H, Kamali F. The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements. Thromb Haemost 2003; 89: 949-50. 
    31. Keech A, Collins R, MacMahon S, et al., Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J 1994; 15: 255-69. 
    32. Gaw A, Wosornu D. Simvastatin during warfarin therapy in hyperlipoproteinaemia. Lancet 1992; 340: 979-80. 
    33. Ahmad S. Gemfibrozil interaction with warfarin sodium (coumadin). Chest 1990; 98: 1041-2. 
    34. Dixon DL, Williams VG. Interaction between gemfibrozil and warfarin: case report and review of the literature. Pharmacotherapy 2009; 29: 744-8. 
    35. Mogyorosi A, Bradley B, Showalter A, Schubert ML. Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin. J Intern Med 1999; 246: 599-602. 
  • 이 논문을 인용한 문헌 (2)

    1. Park, Jinhyun ; Noh, Keumhan ; Lim, Misun ; Kang, Wonku 2013. "Drug-drug Interactions between Atorvastatin and Telmisartan" 한국임상약학회지 = Korean journal of clinical pharmacy, 23(4): 316~321     
    2. Baek, SangHoon ; Park, Sunkyoung ; Jang, Yoo-Jeong ; Lim, Misun ; Kang, Wonku 2013. "Effect of Telmisartan on the Pharmacokinetics of Ebastine" 한국임상약학회지 = Korean journal of clinical pharmacy, 23(4): 322~326     

 저자의 다른 논문

  • Osun, Babatunde (1)

    1. 2011 "지역사회 획득성 폐렴 및 중증 패혈증이 있는 한 환자에게 Linezolid, Moxifloxacin과 Aztreonam을 초회 정맥 주사 후 ALT/AST 수치의 큰 폭 증가 증례 보고" 한국임상약학회지 = Korean journal of clinical pharmacy 21 (4): 394~399    

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기